CAS 1467052-75-0 występuje w naszej ofercie pod nazwami: Tazemetostat hydrobromide/ 99.03% (existing batch purity), Tazemetostat hydrobromide, Tazemetostat hydrobromide, N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide hydrobromide, 98%, 98%. Oferty producentów: TargetMol, GLPBio, Biosynth, Chemat. Dostępne opakowania: 2mg, 5mg, 10mg, 50mg, 100mg, 200mg, 500mg, 10mM (in 1ml dmso).
N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide (CAS 1467052-75-0) to związek chemiczny o wzorze sumarycznym C34H45BrN4O4 i masie molowej 653.6 g/mol. Nazwa systematyczna IUPAC: N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide. InChIKey: UQRICAQPWZSJNF-UHFFFAOYSA-N.
| Wzór sumaryczny | C34H45BrN4O4 |
|---|---|
| Masa molowa | 653.6 g/mol |
| Nazwa IUPAC | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide |
| InChIKey | UQRICAQPWZSJNF-UHFFFAOYSA-N |
| SMILES | CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5.Br |
Dane obliczone przez PubChem (NCBI)